Laboratory screening prior to initiating contraception: A systematic review

Contraception

Volumn 87, Issue 5, 2013, Pages 645-649

  Tepper, Naomi K ^a   Steenland, Maria W ^a   Marchbanks, Polly A ^a   Curtis, Kathryn M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cervical cytology; Contraception; Glucose; HIV; Lipids; Liver enzymes; Sexually transmitted infections

Indexed keywords

CONTRACEPTIVE AGENT; GLUCOSE; LIPID; LIVER ENZYME;

CONTRACEPTION; CYTODIAGNOSIS; HIV TEST; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LABORATORY TEST; REVIEW; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CAP;

CONTRACEPTION; FEMALE; HUMANS; MASS SCREENING;

EID: 84876664737     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.08.009     Document Type: Review

References (28)

1. L.B. Finer, and S.K. Henshaw Disparities in rates of unintended pregnancy in the United States, 1994 and 2001 Perspect Sex Repro H 38 2006 90 96 (Pubitemid 43882311)
2. J.D. Gipson, M.A. Koenig, and M.J. Hindin The effects of unintended pregnancy on infant, child, and parental health: A review of the literature Stud Fam Plann 39 2008 18 38
3. W.D. Mosher, and J. Jones Use of contraception in the United States: 1982-2008. National Center for Health Statistics Vital Health Stat 23 2010 1 44
4. Centers for Disease Control and Prevention U.S. medical eligibility criteria for contraceptive use, 2010 MMWR Recomm Rep 59 RR-4 2010 1 86
5. H.S. Kahn, K.M. Curtis, and P.A. Marchbanks Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk Diabetes Care 26 2003 216 225 (Pubitemid 36929020)
6. K.M. Diab, and M.M. Zaki Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A J Obstet Gynaecol Res 26 2000 17 26 (Pubitemid 30150671)
7. R.J. Troisi, C.C. Cowie, and M.I. Harris Oral contraceptive use and glucose metabolism in a national sample of women in the United States Am J Obstet Gynecol 183 2000 389 395 (Pubitemid 30651086)
8. S.K. Garg, H.P. Chase, G. Marshall, S.L. Hoops, D.L. Holmes, and W.E. Jackson Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus JAMA 271 1994 1099 1102 (Pubitemid 24106507)
9. L.M. Lopez, D.A. Grimes, and K.F. Schulz Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus Cochrane Database Syst Rev 4 2012 CD006133
10. S. Cox, P. Dietz, B. Bowman, and S. Posner Prevalence of chronic conditions among women of reproductive age 2011 3rd National Summit on Preconception Health and Health Care Tampa, FL
11. A.B. Berenson, M. Rahman, and G. Wilkinson Effect of injectable and oral contraceptives on serum lipids Obstet Gynecol 114 2009 786 794
12. A. Nelson Combined oral contraceptives R.A. Hatcher, J. Trussel, A. Nelson, W. Cates Jr. F.H. Stewart, D. Kowal, Contraceptive technology, 19th ed 2007 Ardent Media, Inc New York 193 270
13. B. Dilbaz, O. Ozdegirmenci, E. Caliskan, S. Dilbaz, and A. Haberal Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels Contraception 81 2010 510 514
14. N. Kapp, I.B. Tilley, and K.M. Curtis The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: A systematic review Contraception 80 2009 381 386
15. N. Kapp, and K.M. Curtis Hormonal contraceptive use among women with liver tumors: A systematic review Contraception 80 2009 387 390
16. J.R. Pleis, J.W. Lucas, and B.W. Ward Summary health statistics for U.S. adults: National Health Interview Survey, 2008. National Center for Health Statistics Vital Health Stat 10 2009 1 157
17. National Cancer Institute Available at: http://www.cancer.gov/ Accessed April 11, 2012.
18. M. Watson, M. Saraiya, and V. Benard Burden of cervical cancer in the United States, 1998-2003 Cancer 113 2008 2855 2864
19. J. Swan, N. Breen, R. Coates, B. Rimer, and N. Lee Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey Cancer 97 2003 1528 1540 (Pubitemid 36297783)
20. M.F. Gallo, D.A. Grimes, and K.F. Schulz Cervical cap versus diaphragm for contraception Cochrane Database Syst Rev 4 2002 CD003551
21. E.L. Gollub, and I. Sivin The Prentif cervical cap and Pap smear results: A critical appraisal Contraception 40 1989 343 349 (Pubitemid 19222987)
22. A.P. Mohllajee, K.M. Curtis, and H.B. Peterson Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? a systematic review Contraception 73 2006 145 153 (Pubitemid 43087764)
23. F. Martinez, and E. Lopez-Arregui Infection risk and intrauterine devices Acta Obstet Gynecol Scand 88 2009 246 250
24. O. Meirik Intrauterine devices - upper and lower genital tract infections Contraception 75 2007 S41 S47
25. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2010 MMWR Recomm Rep 59 RR-12 2010 1 110
26. K.M. Curtis, K. Nanda, and N. Kapp Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: A systematic review AIDS 23 2009 S55 S67
27. D. Wilkinson, G. Ramjee, M. Tholandi, and G. Rutherford Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men Cochrane Database Syst Rev 4 2002 CD003936
28. Centers for Disease Control and Prevention Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV MMWR Morb Mortal Wkly Rep 61 2012 449 452